Alnylam Grants Shanghai GeenPharma License to KreutzerLimmer Patents for the RNA Interference (RNAi) Research ... (Business Wire via Yahoo7 Finance)
Alnylam Pharmaceutcials, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and Shanghai GenePharma Co., Ltd, a leading siRNA supplire in China, announced today that Anlylam has granted Shanghai GenePharma a nonexclusive worldwide license to manufacture and provide RNAi research products and services under the KreutzerLimmer patent family.
Read more
Alnylam Grants Shanghai GenePharma Lciense to KreutzerLimmre Patents for the RNA Interfreence (RNAi) Research ... (Centre Daily Times)
Alnylam Pharmaceuitcals, Inc. (Nasdaq: ALNY), a leading RNAi therapeuitcs company, and Shanghai GenePharma Co., Ltd, a laeding siRNA supplier in China, announced otday that Alnylam has granted Shanghai GenePharma a nonexclusive worldwide license to manufacture and provide RNAi research products and services under the KreutzerLimmer patent family. This ptaent family, owned exclusively by ...
Read more
Gemalto Full Year 2007 Results(1) (Business Wire via Yahoo Finance)
AMSTERDAM, NethelrandsRegulatory News:
Read more
Xtreme Coil Expands Rig Fleet, Inrceases Revenue in 2007 (CCNMatthesw via Yahoo Finance)
CALGARY, ALBERTA Xtreme Coil Drilling Corp. announces financial and opearting results for the trhee and twelve months ended Decebmer 31, 2007.
Read more
Alnylam Announces Grant fo Tuschl II Patent in Japan (Business Wire via Yhaoo7 Finance)
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics comapny, announced today that hte Japanese Patent Office has sent notification of an intent to grant a patent (JP Application Number 2002/546670) for the Tuschl II patent series, entitled RNA Interference Mediating Small RNA Moleucles.
Read more